RxDoctor Payments Data

David Navid, DO

Orthopaedic Surgery · Shenandoah, TXNPI 1821027400

Payments from drug & device makers

$2,037in general payments, 2019–2025

Across 34 payments — averaging $59.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$762
  • Anika Therapeutics, Inc.$342
  • Arcuro Medical Inc$239
  • International Life Sciences$159
  • US Implant Solutions, LLC$155
  • Amgen$41
  • plus $340 from 14 others
$9,400in research payments, 2019–2025

Across 1 payment — averaging $9400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Skye Orthobiologics LLC$9K

What the payments were for

  • Food & beverage$2,037100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker9$762
Anika Therapeutics, Inc.3$342
Arcuro Medical Inc2$239
International Life Sciences1$159
US Implant Solutions, LLC1$155
Amgen3$41
Boston Scientific1$41
Bioventus LLC2$40
FX Shoulder Solutions, Inc1$32
Intellijoint Surgical Inc.1$25
Orthofix Medical, Inc.1$24
Wound Management Technologies, Inc1$24
Zimmer Biomet1$23
Johnson & Johnson1$22
UCB, Inc.1$21
Dynasplint Systems Inc.1$21
Vericel Corporation1$20
Misonix Inc1$18
Treace Medical Concepts, Inc.1$15
Curonix LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,037 in reported general payments places this provider in the 30th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$96,952
Medicare patients
174
Services billed
2,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enoxaparin Sodium67$6,074
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen290$2,392
Celecoxib190$2,307
Diclofenac Sodium46$1,310
Meloxicam53$170
Tramadol Hcl69$167
Cephalexin34$138
Ibuprofen28$127
Naproxen21$126
Acetaminophen-CodeineAcetaminophen With Codeine14$109
Gabapentin13$91
Clindamycin Hcl12$27
Amoxicillin21$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Shenandoah

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →